MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pharming Group Company Profile (NASDAQ:PHGUF)

Consensus Ratings for Pharming Group (NASDAQ:PHGUF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Pharming Group (NASDAQ:PHGUF)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Pharming Group (NASDAQ:PHGUF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
3/5/2015$0.04$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Pharming Group (NASDAQ:PHGUF)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Pharming Group (NASDAQ:PHGUF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Pharming Group (NASDAQ:PHGUF)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Pharming Group (NASDAQ:PHGUF)
DateHeadline
05/14/16 01:31 PMPharming Group N.V. : quaterly earnings release - 01/07 PHARMING: Stifel Financial Corp. (PHARM.NA, Buy) – Enrolment completed in.. 01/06 PHARMING: Roth Capital – PHGUF: Prophylactic Data by End of 2Q16 to Help .. 01/06 PHARMING: (PHARM.NA, Buy) – Enrolment completed in Ruconest Phase II prop..
05/12/16 01:29 PMPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Increased By 163.41% Their Shorts - B.O.D.Y Confidential - PHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Increased By 163.41% Their ShortsB.O.D.Y ConfidentialThe stock of PHARMING GROUP NV LEID (OTCMKTS:PHGUF) registered an increase of 163.41% in short interest. PHGUF's total short interest was 32,400 shares in May as published by FINRA. Its up 163.41% from 12,300 shares, reported previously.
05/11/16 01:34 PMStock Analysts' Upgrades for May, 11th (AWR, CIU, CMO, DWSN, FAN, FIS, IVR, JAZZ, JSAIY, KGC) - Washington News Wire - Stock Analysts' Upgrades for May, 11th (AWR, CIU, CMO, DWSN, FAN, FIS, IVR, JAZZ, JSAIY, KGC)Washington News WirePharming Group (NASDAQ:PHGUF) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Pharming Group NV develops innovative therapeutics for the treatment of genetic disorders, specialty ...and more »
05/07/16 01:06 PMPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Shorted Shares Increased 163.41% After Market Selling - B.O.D.Y Confidential - PHARMING GROUP NV LEID (OTCMKTS:PHGUF) Shorted Shares Increased 163.41% After Market SellingB.O.D.Y ConfidentialThe stock of PHARMING GROUP NV LEID (OTCMKTS:PHGUF) registered an increase of 163.41% in short interest. PHGUF's total short interest was 32,400 shares in May as published by FINRA. Its up 163.41% from 12,300 shares, reported previously.
04/14/16 01:32 PMPHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Covered 59.54% of Their Shorts - Clinton Financial - PHARMING GROUP NV LEID (OTCMKTS:PHGUF) Sellers Covered 59.54% of Their ShortsClinton FinancialThe stock of PHARMING GROUP NV LEID (OTCMKTS:PHGUF) registered a decrease of 59.54% in short interest. PHGUF's total short interest was 12,300 shares in April as published by FINRA. Its down 59.54% from 30,400 shares, reported previously.Analysts Expect Pharming Group (NASDAQ:PHGUF) to Announce ($0.01) EPSWeb Breaking Newsall 2 news articles »
03/02/16 11:49 AMAnalysis and Pharming Group N.V. (PHGUF) Earnings Review - OctaFinance.com - Analysis and Pharming Group N.V. (PHGUF) Earnings ReviewOctaFinance.comAnalysts await Pharming Group N.V. (PHGUF) to reports earnings on March, 2. The stock closed at $0.35 during the last session. It is down 6.00% since January 30, 2016 and is uptrending. It has outperformed by 13.33% the S&P500.
02/24/16 11:50 AMAnalysis and Pharming Group NV (PHGUF) Earnings Review - Clinton Financial - Analysis and Pharming Group NV (PHGUF) Earnings ReviewClinton FinancialWall Street await Pharming Group N.V. (PHGUF) to release earnings on February, 24. The stock closed at $0.35 during the last session. It is down 6.00% since January 24, 2016 and is uptrending. It has outperformed by 14.52% the S&P500.
01/27/16 10:43 AMA European Biotech Stock Basket For 2016 - Seeking Alpha - Seeking AlphaA European Biotech Stock Basket For 2016Seeking AlphaDisclosure: I am/we are long TGXSF, GNFTF, OXNXF, ARGNF. (More...)I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company ...
About Pharming Group

Pharming Group logoPharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company's products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming's technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company's commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PHGUF
  • CUSIP:
Key Metrics:
  • Previous Close: $0.19
  • 50 Day Moving Average: $0.00
  • 200 Day Moving Average: $0.00
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $78.38M
  • Current Quarter EPS Consensus Estimate: $-0.03 EPS
Additional Links:
Pharming Group (NASDAQ:PHGUF) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha